Ingersoll RandNYSE: IR

DAVIDSON, N.C., June 27, 2024 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, has unveiled its 2023 Sustainability Report. “ Leading Sustainably through execution ” details the company's commitment, action, and accomplishments related to a more sustainable future, guided by Ingersoll Rand Execution Excellence (IRX) and an ownership mindset.

DAVIDSON, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, today announced Scott Watson, former chief operating officer of ILC Dover (“ILC”), to serve as the senior vice president and general manager of the Life Science Technologies platform, effective immediately. He succeeds Corey Walker, who left the company to pursue an external opportunity.

Ingersoll Rand Inc. saw a sequential acceleration in orders and marketing qualified leads last quarter which should help improve its organic growth in the coming quarters. The company's exposure to megatrends like reshoring and sustainability, and focus on digital initiatives, and increasing recurring aftermarket revenues bodes well for medium to long-term growth. Margin growth is expected from operating leverage, price increases, and margin accretive acquisitions, supporting a buy rating on the stock.

Ingersoll Rand (IR) benefits from strength in the Industrial Technologies & Services segment. Its measures to reward its shareholders are encouraging.

The acquisition of ILC Dover enables Ingersoll Rand (IR) to strengthen its product offerings in the life sciences market.

Ingersoll Rand Inc., a worldwide supplier of essential flow creation and industrial solutions, revealed that Vik Kini, CFO, and Matthew Fort, VP of Investor Relations and Corporate FP&A, will be taking part in a fireside chat at the Wolfe 17th Annual Global Transportation and Industrials Conference on May 22, 2024, at 8:00 a.m. ET.

Ingersoll Rand (IR) is benefiting from the strong performance of its various business segments, acquisitions, and shareholder-friendly initiatives. However, the weakness in its life sciences division is a cause for worry.

Ingersoll Rand (IR) announced adjusted earnings of 78 cents per share for the first quarter of 2024, exceeding the Zacks Consensus Estimate of 69 cents. The bottom line grew by 20% compared to the previous year.

The financial results for Ingersoll (IR) in the quarter ending March 2024 provide insight into the company's performance, but it may be beneficial to examine how certain key metrics compare to analyst expectations and the previous year.